Results 51 to 60 of about 29,769 (281)

Incidence and survival of vulvar and vaginal cancers in a province of Northern Italy: a population-based study

Gynecologic Oncology Reports
Background: This study aims to describe the incidence, mortality, and survival trends of vulvar and vaginal cancers in a population-based cohort from Northern Italy, with a particular focus on the development of second primary malignancies. Methods: Data
Isabella Bisceglia, Francesco Marinelli, Vincenzo Dario Mandato, Debora Pirillo, Fortunato Morabito, Antonino Neri, Lucia Mangone   +6 more
doaj   +1 more source

Descriptive epidemiology of vulvar and vaginal cancers in Vaud, Switzerland, 1974-1994 [PDF]

, 2017
Background: To analyse trends in incidence, survival and risk of second neoplasms following vaginal and vulvar cancers using data collected by the Swiss Cancer Registry of Vaud over the 21-year period 1974-1994.
La Vecchia, C., Levi, F., Randimbison, L.   +2 more
core  

Treatment of symptoms of the menopause: an endocrine society clinical practice guideline [PDF]

, 2015
Objective: The objective of this document is to generate a practice guideline for the management and treatment of symptoms of the menopause. Participants: The Treatment of Symptoms of the Menopause Task Force included six experts, a methodologist, and
Davis, Susan R., Gompel, Anne, Lumsden, Mary Ann, Murad, M. Hassan, Pinkerton, JoAnn V., Santen, Richard J., Stuenkel, Cynthia A.   +6 more
core   +1 more source

Trends in the incidence of cancers of the breast and female genital tract in Harare, Zimbabwe 1990–2019

International Journal of Cancer, EarlyView.
What's New? Cancers of the breast and female genital tract represent more than half of all cancers in women in sub‐Saharan Africa. Here, the authors assessed incidence trends in a female population living in urban sub‐Saharan Africa based on the Zimbabwe National Cancer Registry in Harare over a 30‐year period.
Eric Chokunonga, Zvavahera Michael Chirenje, Margaret Borok, Rudo Makunike‐Mutasa, Ntokozo Ndlovu, Justice Mudavanhu, Biying Liu, D. Maxwell Parkin   +7 more
wiley   +1 more source

Atrophic vulvar lichen sclerosus evolving to an epidermoid carcinoma: about an uncommon case

PAMJ Clinical Medicine, 2019
Malignant tumors of the vulva are usually budding, ulcerated, or infiltrating. The fear of cancer must always be in mind, in front of any vulvar lesion.
Abderrahim Siati, Aziz Slaoui, Sarah Talib, Abdelaziz Baidada, Aicha Kharbach   +4 more
doaj   +1 more source

Human papillomavirus and HPV vaccines: a review [PDF]

, 2007
Cervical cancer, the most common cancer affecting women in developing countries, is caused by persistent infection with "high-risk" genotypes of human papillomaviruses (HPV). The most common oncogenic HPV genotypes are 16 and 18, causing approximately 70%
Castellsague, X., Claeys, P., Cutts, F. T., de Sanjose, S., Edmunds, W. J., Franceschi, S., Garnett, G., Goldenthal, K. L., Goldie, S., Harper, D. M., Markowitz, L.   +10 more
core   +3 more sources

Risk stratification and anal cancer screening in immunocompetent women with genital HPV: Value of multicentric HSIL and performance of HPV‐based screening

International Journal of Cancer, EarlyView.
What's New? Anal squamous cell carcinoma (ASCC) incidence is increasing, with most cases occurring in immunocompetent women. ASCC risk is linked in particular to genital human papillomavirus (HPV) infection and HPV‐associated high‐grade squamous intraepithelial lesions (HSILs).
Isabel Matas, Aureli Torné, Adela Saco, Cristina Martí, Ada Cardiel, Natalia Rakislova, Lorena Marimon, Ariel Glickman, Ingrid Victoria, Silvia Alós, Jesús Lopez‐Diaz, Pere Fusté, Jaume Ordi, Marta del Pino   +13 more
wiley   +1 more source

Incidence Trends of Vulvar Cancer in the United States: A 20‐Year Population‐Based Study

Cancer Reports
Background Despite being uncommon, vulvar cancer is a serious health concern with a 5‐year relative survival rate of 71%. Aims The objective was to investigate the incidence rates of this disease across different racial, ethnic, and histological ...
Seyed Ehsan Mousavi, Hoomaan Ghasemi, Morvarid Najafi, Zahra Yekta, Seyed Aria Nejadghaderi   +4 more
doaj   +1 more source

Vulvar cancer in Tunisia: Epidemiological and clinicopathological features multicentric study

Journal of the Egyptian National Cancer Institute, 2017
Objective: To describe for the first time the epidemiologic and clinico-pathologic characteristics of vulvar cancer in Tunisia. Design: Two parts are distinguished in this study: Part1: Multicentric retrospective study about the characteristics of all ...
Mehdi Kehila, MD, Souad Harabi, MD, Raoudha Mhiri, MD, Omar Touhami, MD, Hassine Saber Abouda, MD, Abdeljalil Khlifi, MD, Mohamed Hsairi, PhD, Dalenda Chelli, PhD, Mohamed Derbel, MD, Sahbi Kebaili, MD, Nadia Boujelbane, MD, Kais Chaabene, PhD, Mohamed Badis Chanoufi, PhD   +12 more
doaj   +1 more source

Interstitial brachytherapy with 192Ir in vulvar cancer [PDF]

, 2006
Vulvar cancer accounts for 5% of all female genital cancers and 1% of all malignancies in women. A female patient, 78 years old, with diagnosed squamous cell carcinoma of vulva stage II, was admitted to our Institution in January 2004. An exophytic tumor,
Baucal Milutin, Bugarčić Biljana, Erak Dragica, Erak Marko, Mandić Aljoša, Novaković Petar   +5 more
core   +1 more source